The purpose of this research study is to review the ability of the Exact Sciences’ Minimal Residual Disease (Exact MRD) test to detect cancer recurrence after surgery.
Learn more about the 16-002 / NSABP C-14 trial or call the Reading Hospital Cancer Research Office at 484-628-8193.
